With a history of 170 years, Aspen is a multinational pharmaceutical company with a presence in both emerging and developed markets. It has approximately 9,100 employees,...
Sandoz was spun off from Novartis on October 4th, following its listing on the Swiss SIX stock exchange. Sandoz works with generic or biosimilar medicines with...
Novartis is aiming for its annual sales to grow in the high single digits this year when it previously estimated they would grow in the mid-single...
The Swiss pharmaceutical company plans to lay off 8,000 workers worldwide, equivalent to 7.7% of the total workforce. The Novartis job cuts are part of the...
The global slowdown in economic growth has so far left Roche and Novartis' businesses untouched. Both drug manufacturers, based in Basel, are currently growing significantly faster...